1. Home
  2. FRT vs EXAS Comparison

FRT vs EXAS Comparison

Compare FRT & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRT
  • EXAS
  • Stock Information
  • Founded
  • FRT 1962
  • EXAS 1995
  • Country
  • FRT United States
  • EXAS United States
  • Employees
  • FRT N/A
  • EXAS N/A
  • Industry
  • FRT Real Estate Investment Trusts
  • EXAS Medical Specialities
  • Sector
  • FRT Real Estate
  • EXAS Health Care
  • Exchange
  • FRT Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • FRT 9.0B
  • EXAS 10.5B
  • IPO Year
  • FRT N/A
  • EXAS N/A
  • Fundamental
  • Price
  • FRT $104.28
  • EXAS $49.26
  • Analyst Decision
  • FRT Buy
  • EXAS Strong Buy
  • Analyst Count
  • FRT 17
  • EXAS 17
  • Target Price
  • FRT $121.24
  • EXAS $72.31
  • AVG Volume (30 Days)
  • FRT 813.6K
  • EXAS 2.0M
  • Earning Date
  • FRT 02-13-2025
  • EXAS 02-19-2025
  • Dividend Yield
  • FRT 4.22%
  • EXAS N/A
  • EPS Growth
  • FRT 22.15
  • EXAS N/A
  • EPS
  • FRT 3.42
  • EXAS N/A
  • Revenue
  • FRT $1,205,612,000.00
  • EXAS $2,758,867,000.00
  • Revenue This Year
  • FRT N/A
  • EXAS $12.09
  • Revenue Next Year
  • FRT $4.40
  • EXAS $11.24
  • P/E Ratio
  • FRT $30.48
  • EXAS N/A
  • Revenue Growth
  • FRT 6.13
  • EXAS 10.37
  • 52 Week Low
  • FRT $95.98
  • EXAS $40.62
  • 52 Week High
  • FRT $118.34
  • EXAS $79.62
  • Technical
  • Relative Strength Index (RSI)
  • FRT 38.58
  • EXAS 33.51
  • Support Level
  • FRT $103.66
  • EXAS $45.94
  • Resistance Level
  • FRT $105.75
  • EXAS $51.75
  • Average True Range (ATR)
  • FRT 2.00
  • EXAS 2.13
  • MACD
  • FRT -0.56
  • EXAS -0.30
  • Stochastic Oscillator
  • FRT 7.71
  • EXAS 32.20

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: